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Key Clinical Message
Although resection of multilobular tumors of bone can be associated with a
good prognosis and long disease-free intervals in dogs, osteosarcomatous trans-
formation should be considered a cause for rapid recurrence of clinical signs.
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Case Report
A 2-year and 11-month-old male neutered Jack Russell
Terrier presented to the Queen Mother Hospital for Ani-
mals, the Royal Veterinary College, University of London
for further evaluation of focal seizures and cervical hyper-
esthesia of 7-day duration. General physical examination
was within normal limits. Neurological examination
revealed obtundation, bilaterally absent menace responses,
and cervical hyperesthesia. No other abnormalities were
noted during the neurological examination. A multifocal
neuroanatomical localization with forebrain and cervical
spinal cord involvement was considered most likely.
Results of a complete blood count and a biochemistry
profile were within normal limits. The dog was premedi-
cated with methadone 0.1 mg/kg IV. Diazepam (0.3 mg/
kg IV) was administered prior to induction of anesthesia
with propofol (4-6 mg/kg IV dosed to effect). Anesthesia
was maintained with sevoflurane vaporized in oxygen.
Magnetic resonance imaging (MRI; 1.5T Intera, Philips
Medical Systems, Eindhoven, the Netherlands) of the
head included sagittal and transverse plane T2-weighted
fast spin echo (repetition time [ms] [TR], echo time [ms]
[TE], 2882/110 in sagittal, and 5099/110 in transversal
plane), transverse plane T2-weighted fluid-attenuated
inversion recovery (FLAIR) (TR/TE, 6000/120), and trans-
verse T2*-weighted gradient echo sequences (TR/TE, 753/
23, 18° flip-angle). Sagittal and transverse plane T1-
weighted turbo-spin echo (T1W TSE) (TR/TE, 450/15)
images were acquired before and after IV injection with
gadolinium contrast (0.1 mmol/kg gadobutrol, Bayer plc,
Strawberry Hill, UK). MRI examination demonstrated a
large (20 mm 9 21 mm 9 18 mm), well-demarcated,
irregularly margined, left-sided, extra-axial mass, arising
with a broad base from the left occipital bone, compress-
ing the left occipital lobe and left cerebellar hemisphere
(Fig. 1A and B). The mass was hypointense on T2-
weighted, T1-weighted, FLAIR, and T2*-weighted
gradient echo sequences compared to surrounding brain
parenchyma. Peripheral contrast enhancement was pre-
sent, and raised intracranial pressure was suggested by the
presence of a midline shift and foramen magnum hernia-
tion. MRI of the cervical spinal cord demonstrated syrin-
gomyelia. A subsequent computed tomography (CT;
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MX8000 IDT, Philips Medical Systems) study of the tho-
rax and abdomen was within normal limits, while CT of
the head demonstrated the mass to have a similar attenu-
ation to bone (Fig. 1C). Although the largest portion of
the mass was within the cranial vault, an extracranial por-
tion was evident, with distortion of the lateral aspect of
the occipital and parietal bones. Multilobular tumor of
bone, osteosarcoma, and chondroma was considered the
most likely differential diagnoses at this time. The dog
was anesthetized the next day with the aforementioned
protocol and positioned in sternal recumbency. A com-
bined left-sided rostrotentorial and caudal fossa cran-
iotomy were performed, which allowed removal of the
well-defined bony mass en bloc (Fig. 2). The wound was
closed routinely without performing a cranioplasty. The
dog recovered uneventfully from anesthesia. Intraopera-
tive analgesia consisted of an IV constant rate infusion of
remifentanil (0.15–0.4 lg/kg/min), while early postopera-
tive analgesia consisted of a combination of paracetamol
(10 mg/kg IV q12 h), methadone (0.1–0.2 mg/kg IV
q4 h), and dexamethasone (0.2 mg/kg IV q24 h). The
dog demonstrated ambulatory cerebellar ataxia and
bilaterally absent menace responses the day after surgery.
He gradually improved, was discharged from hospitaliza-
tion 5 days after surgery and was, according to the own-
ers, neurologically normal 7 days after surgery.
Histopathological examination of cruciate sections repre-
sentative of the mass and surgical margins revealed a neo-
plasm composed of multiple islands and anastomosing
trabeculae of well-differentiated woven bone and occa-
sional cartilage surrounded by few polygonal to spindloid
cells, separated by thin, irregular fibrovascular septa.
There was mild anisocytosis and anisokaryosis, and five
mitoses were observed in 10 high-power fields (Fig. 3).
Neoplastic cells extended to the surgical margins. These
findings were consistent with a multilobular tumor of
bone (grade II) [1]. Eight days after surgery, the dog
developed hypermetria of the left thoracic limb, which
rapidly progressed to nonambulatory ataxia and a right-
sided head tilt. Neurological examination revealed non-
ambulatory vestibular ataxia, with a right-sided head tilt
and a tendency for rolling and falling to the right side, a
miotic right pupil, and disconjugate nystagmus, which
changed directions with changes in position of the head.
(A) (B)
(C) (D)
Figure 1. T2-weighted sagittal (A) and T2-weighted transverse (B) MR images and a CT image (C) of a 2-year and 11-month-old male Jack
Russell Terrier presented for further evaluation of focal seizures and cervical hyperesthesia. Transverse T2-weighted MR image at the time of
recurrence of clinical signs (D). (A and B) A large, extra-axial, left-sided, hypointense mass associated with the skull (arrow) causes compression of
the occipital lobe and left cerebellar hemisphere. (C) The mass is isodense to bone and contains stippled mineralized densities (arrow). (D) A
poorly demarcated hypointense mass lesion is visible at the same site of previous tumor resection (arrow). The mass is surrounded by a large
amount of perilesional edema, which is possibly caused by the previous surgery.
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These findings were suggestive for a central vestibular
syndrome. General anesthesia was induced and main-
tained with the aforementioned protocol. Repeat MRI
examination of the head revealed a large, poorly demar-
cated, extra-axial mass lesion at the site of the previous
surgery. The lesion had a heterogeneous, predominantly
hypointense intensity on all sequences compared to sur-
rounding brain parenchyma (Fig. 1D). No IV contrast
medium was administered during this study. Hematoma
formation at the site of surgery and/or tumor regrowth
was considered the most likely causes for this postopera-
tive neurological deterioration. The next day, the dog was
anesthetized again as described above and underwent sur-
gical exploration of the previous surgery site. Surgery
revealed a large firm mass lesion at the same site of previ-
ous tumor resection (Fig. 2C), suggesting tumor
regrowth. At this time, the owners of the dog elected
euthanasia during surgery. Postmortem examination
revealed a roughly spherical, 20 9 15 9 15 mm bony
mass that compressed the left occipital lobe and left cere-
bellar hemisphere (Fig. 2D). Gross postmortem examina-
tion of the thoracic cavity, abdominal cavity,
appendicular, and axial skeleton did not reveal any evi-
dence of tumor metastasis. Histopathological examination
of the mass revealed disorganized sheets of polygonal to
spindloid cells, with occasional fibrous septa and blood
vessels. There were disorganized islands and trabeculae of
osteoid, woven bone, chondroid matrix and cartilage, and
extensive necrosis. Anisocytosis and anisokaryosis were
marked, and 12 mitoses were counted per 10 high-power
fields (Fig. 3). The underlying compressed cerebellum was
partially malacic (necrotic). These findings were consis-
tent with a multilobular tumor of bone with osteosarco-
matous differentiation (grade III) [1].
Discussion
Multilobular tumors of bone (MTBs) (synonyms; multi-
lobular osteochondrosarcoma, chondroma rodens, carti-
lage analogue of fibromatosis, calcifying aponeurotic
fibroma, juvenile aponeurotic fibroma and multilobular
chondroma or osteoma) are uncommon, but not rare,
neoplasms in dogs, which most often affect the flat bones
of the skull [2]. Multiple additional sites including the
axilla, hard palate, os penis, ribs and pelvis have also been
reported [2–8]. Although the most common clinical pre-
sentation is that of a solid and firm mass of the skull,
neurological signs can result if compression of the brain
occurs. The nature of neurological signs is then reflected
by the specific location of the neoplasm. MTB is typically
(A) (B)
(C) (D)
Figure 2. Intraoperative pictures of initial tumor removal (A and B), second surgery after recurrence of clinical sigs (C) and post mortem
evaluation (D). (A) A mass associated with the skull is clearly visible (arrow). Rostral to the left and occipital protuberance indicated by OP. (B)
Tumor removed en bloc after craniotomy. Rostral to the left. Forebrain (FB), tentorium cerebelli (TC), and cerebellum (C) indicated. (C) Second
surgery 11 days after the first surgery indicates tumor regrowth (arrow) at the same site as the previous surgery. Rostral is to the left. (D) Large
extra-axial mass visible at the same site as previous tumor removal.
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a slow-growing and locally invasive neoplasm with mod-
erate potential for metastasis [2]. The relatively slow
growth rate of this tumor allows it to grow to a relatively
large size prior to causing clinical signs [2].
Multilobular tumors of bone are locally invasive, and
recurrence after surgical resection is therefore common.
Recurrence occurs typically only after a prolonged period
of time and affected dogs therefore have a long disease-
free interval and long survival times after surgery [1, 2].
In dogs undergoing surgical excision, with or without
adjunctive radio- and/or chemotherapy, median time to
recurrence was 14 months, while the median survival
time was 22 months [1]. Even longer survival times were
reported in another study, indicating median survival
times and times to recurrence of 797 days after surgery
[2]. In dogs receiving chemotherapy alone a median sur-
vival of 144 days is reported [9]. Surgery therefore
remains the treatment of choice and predictably, time to
local recurrence has been reported to be shorter in dogs
with a higher tumor grade (grade I to III, in which grade
III represents the most malignant grade) and incomplete
surgical margins (disease-free interval 330 days vs.
1332 days with complete surgical margins) [2]. Despite
the presence of incomplete surgical margins in the dog
described in this report, local recurrence in 8 days was
still considered an unusually short disease-free interval.
Histopathological examination of both the originally
excised tumor and the recurrent tumor revealed substan-
tial morphological differences. The tissue obtained during
the first surgery demonstrated relatively benign character-
istics including a well-organized lobular or trabecular
structure, low cellularity and mild cellular pleomorphism,
typical of MTB. The tumor regrowth, on the other hand,
displayed a markedly disorganized structure, high cellular-
ity, extensive necrosis, marked cellular pleomorphism,
and a higher mitotic count. These histopathological find-
ings were considered consistent with osteosarcomatous
transformation [10].
Although MTB with more malignant characteristics has
occasionally been reported, the authors of this report are
unaware of previous cases that experienced such rapid
tumor regrowth [1, 2, 7]. Little information is therefore
available on the frequency and risk factors for malignant
transformation of MTB in dogs. It is possible that the com-
bination of pre-existing hypoxia within malignant tissue,
tumor-derived immunosuppression, a local inflammatory
environment, and borderline immunosuppressive doses of
dexamethasone postprocedurally, all created an environment
conducive for malignant transformation [11–13]. Although
the tumor was resected en bloc, microscopic examination
indicated that tumor-free surgical margins had not been
achieved. It can therefore also not be excluded that the most
(A) (B)
(C) (D)
Figure 3. H&E stained sections of a multilobular tumor of bone removed during the first surgery (A and B) and during postmortem examination
after tumor regrowth was observed (C and D). (A) Anastomosing trabeculae of mature bone (B) and occasional cartilage (block arrow) separated
by fine fibrovascular septa (920, bar = 1 mm). (B) Fibrovascular septa (asterisk) and low numbers of neoplastic cells (NC) surrounding the bony
trabeculae (B) (9100, bar = 250 lm). (C) There is loss of trabecular architecture with neoplastic cells arranged in sheets with occasional blood
vessels (arrowhead). Inset – marked cellular and nuclear pleomorphism, prominent nucleoli, and a mitotic figure (line arrow) (9100,
bar = 250 lm, inset bar = 10 lm). (D) Neoplastic cells undergo multifocal chondroid (C) and osseous (O) differentiation (9200, bar = 100 lm).
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peripheral parts of the tumor already demonstrated more
malignant characteristics and that examination of the
incompletely resected tumor therefore underestimated its
malignant potential. It should also be noted that other clini-
cal indications of malignancy, including presence of metas-
tases, were not observed during the initial diagnostic
investigations or postmortem examination.
p53 index, as assessed by immunohistochemical label-
ing, has been reported to show a strong correlation with
typical features of malignancy including histologic grade
and mitotic index [14]. Given the high grade and mitotic
index of the second sample, a high p53 index would be
expected. Although MTBs typically occur in middle to
old-aged (median 8 years), medium to large-breed dogs,
the dog in this report was less than 3 years old and con-
sidered a small-breed dog as is rarely reported [2, 7, 10].
The dog in this report also experienced a short duration
of observed clinical signs before he was admitted for ini-
tial diagnostic investigations. It is, however, unclear if the
atypical breed, the young age of the dog, and the short
duration of clinical signs presented here could indeed be
associated with a more malignant character of the diag-
nosed MTB. Further studies are therefore necessary to
evaluate if signalment and clinical presentation can be
used as prognostic indicators for dogs with MTB.
This case report indicates that although resection of
MTBs is typically associated with a good prognosis, long
disease-free intervals, and prolonged survival, malignant
transformation of residual tumor should be considered a
potential cause for rapid recurrence of clinical signs. Fur-
ther studies are necessary to evaluate risk factors for
transformation for this type of neoplasia.
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